Peptide appearance Lyophilized form

Healing and Regeneration

15 000+ verified orders

GHK-CU

In stock

GHK-Cu (Copper Peptide), a naturally occurring peptide composed of three amino acids (glycyl-L-histidyl-L-lysine), has been extensively studied for its potential in wound healing, tissue regeneration, and skin rejuvenation. It stimulates blood vessel and nerve outgrowth and increases collagen, elastin, and glycosaminoglycan synthesis. GHK-Cu supports the function of dermal fibroblasts, contributing to improved tissue repair in various organs, including the skin, lungs, bones, liver, and stomach lining. Additionally, GHK-Cu exhibits powerful cell protective actions, such as anti-cancer and anti-inflammatory effects, lung protection, suppression of aging-related molecules like NFκB, and enhancement of DNA repair and cell cleansing via the proteasome system.
Available strengths
38,50 €
Buy 2, get 1 free. €100 in paid peptide vials · water excluded
Bundle & save

Arrives 26 – 30 November to Europe

We accept Visa Mastercard Apple Pay (when supported) Google Pay (when supported) Klarna (where available) Shown at checkout

GHK-CU

Price range: 38,50 € through 62,00 €

GHK-Cu copper peptide complex for matrix, copper-signalling, and remodeling studies.

Compound information

Specifications

Molecular profile

Sequence
Gly-His-Lys
Molecular mass
401.91 g/mol
CAS number
89030-95-5
Molecular formula
C14H22CuN6O4

Material record

Physical appearance
Blue to blue-green lyophilized powder
Salt form
1:1 GHK–Cu(II) complex
Solubility
Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
Product note
Copper-binding tripeptide complex; supplied strictly for research use only.

Research overview

GHK-CU

Description of GHK-Cu

The human copper-binding peptide GHK-Cu (glycyl-l-histidyl-l-lysine) is a naturally occurring tri-peptide found in human plasma and released from tissues during injury. Discovered in 1973, GHK-Cu has established itself as a extensively studied protective and regenerative compound, widely used in skin and hair products. In research and cosmetic contexts, GHK-Cu has been associated with tightening loose skin, repairing protective skin barrier proteins, and improving skin firmness, elasticity, and clarity. It has been studied in relation to fine lines, wrinkles, and photodamage, and smoothing rough skin. Additionally, GHK-Cu has been investigated for its role in wound healing, protection of skin cells from UV radiation, reduction of inflammation and free radical damage, and enhancement of hair growth and thickness. Its effects are largely attributed to its ability to bind copper(II) ions, playing a crucial role in copper metabolism. Recent research, utilizing the Connectivity Map from the Broad Institute, has shown that GHK-Cu can up- and down-regulate numerous human genes, linking its biological effects to changes in gene expression.

Mechanism of Action

GHK-Cu binds copper ions and incorporates them into regenerative metabolic pathways, activating:

  • Collagen Synthesis → Promotes tissue rebuilding, skin firmness, and scar repair
  • Angiogenesis → Supports new blood vessel formation for improved tissue healing
  • Antioxidant Enzymes → Protects against free radicals and cellular stress
  • Gene Regulation → Activates over 4,000 genes involved in healing, anti-inflammation, and anti-aging processes

Further research on GHK-Cu reveals its presence in human blood plasma, urine, and saliva. Animal studies indicate that GHK-Cu can significantly influence wound healing, immune function, and skin health by stimulating collagen production, promoting blood vessel growth, and supporting fibroblast activity.

Why Choose GHK-Cu?

  • GHK-Cu is unique among peptides for its targeted regenerative and anti-aging effects.
  • While many peptides focus on fat loss or muscle gain, GHK-Cu directly supports skin, connective tissue, and cellular repair.
  • It is one of the most respected peptides in both aesthetic and regenerative medicine research, valued for its safety, biological compatibility, and broad spectrum of action.

Order GHK-Cu and explore its potential in regeneration, skin rejuvenation, and advanced anti-aging research.

Now we would like to bring you closer to the effects of the peptide, which have been researched and confirmed in studies.

[3]

Overview of Published Research

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring peptide in human plasma, saliva, and urine that declines with age. Known for its extensively researched protective and regenerative properties, GHK-Cu has been shown to accelerate wound healing and skin repair by stimulating the synthesis and breakdown of collagen, glycosaminoglycans, and other extracellular matrix components. It modulates the activity of metalloproteinases and their inhibitors, promoting the healing of various tissues such as skin, hair follicles, and bones. In cosmetic products, GHK-Cu has been studied in the context of tightening loose skin, improving elasticity and firmness, reducing fine lines, wrinkles, and hyperpigmentation, and enhancing overall skin appearance. Additionally, it has been investigated for potential relevance to conditions like skin inflammation, chronic obstructive pulmonary disease, and metastatic colon cancer, owing to its ability to regulate thousands of human genes, with observed effects on resetting DNA expression patterns.

Recent studies have highlighted GHK-Cu's role in modulating key growth factors involved in wound healing and skin regeneration. Transforming growth factor β (TGF-β) and insulin growth factor (IGF) are crucial in these processes, with GHK-Cu shown to decrease IGF-2-dependent TGF-β1 secretion in dermal fibroblasts, potentially preventing hypertrophic scar formation. Furthermore, GHK-Cu encapsulated in liposomes has been demonstrated to accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis, enhancing the expression of vascular endothelial growth factor and fibroblast growth factors, and improving the overall healing process. These findings underscore the peptide's potential as a subject of further research in skin regeneration and wound healing.

[1] - [4]

In vitro studies have highlighted the promising antimicrobial activity of Gly-His-Lys conjugates as candidates for further research into skin and tissue infections. These studies explored novel compounds, including fatty acid conjugates with modified Gly-His-Lys sequences. The antimicrobial efficacy of these compounds ranged from strong to moderate. Notably, compound 1d exhibited the most potent activity against Escherichia coli and Staphylococcus aureus with MIC ranges of 31.3–125.0 μg/mL and against Pseudomonas aeruginosa with MIC ranges of 375.0–500.0 μg/mL. Conjugate 5b showed significant activity against Staphylococcus aureus and Escherichia coli at MIC ranges of 250.0–500.0 μg/mL and 62.5–125.0 μg/mL, respectively. Both 1d and 5b demonstrated rapid bactericidal effects against Gram-positive bacteria. Additionally, compounds 1d, 1e, and 2e showed notable antifungal activity.

A multicenter, randomized, evaluator-blinded, placebo-controlled clinical study evaluated the effectiveness of the glycyl-L-histidyl-L-lysine copper complex (lamin Gel) in treating diabetic neuropathic ulcers. Patients adhered to a standardized wound care protocol, including sharp debridement, daily drug application, pressure-relieving footwear, and diabetes management education. Treatment with lamin Gel significantly improved ulcer closure rates, achieving a median area closure of 98.5% compared to 60.8% for the control group. The rate of closure was three times faster with lamin Gel, particularly for larger ulcers (greater than 100 mm²), which showed an 89.2% closure compared to -10.3% for the control. Immediate treatment post-debridement was crucial for optimal results. Additionally, the incidence of ulcer infections was significantly lower in the lamin Gel group (7%) compared to the control (34%).

An experimental study on the effects of topical glycyl-L-histidyl-L-lysine tripeptide-copper complex (TCC) on ischemic open wounds in rats further supported the observed activity of GHK-Cu. Rats treated with TCC showed a significant decrease in wound area compared to control and vehicle groups. By day 13, the TCC group exhibited a 64.5% reduction in wound area, outperforming the vehicle (45.6%) and control (28.2%) groups. TCC-treated wounds also had significantly lower concentrations of TNF-alpha and MMP-2 and MMP-9, indicating reduced inflammation and enhanced healing. These findings suggest that TCC could be of research interest as an approach for chronic wounds in various species, including humans.

Overall, GHK-Cu has shown notable results in research models of diabetic ulcers and ischemic open wounds compared to standard care alone. Its combination with certain fatty acids creates a potent antimicrobial compound with activity against bacteria and fungi, with observed reductions in infection rates and acceleration of wound healing. These findings warrant further research evaluation of GHK-Cu in the context of wound care.

[5] - [7]

Neurodegeneration, characterized by the progressive death of neurons and cognitive decline, is a growing concern among senior populations, with limited effective research approaches available. One compound of research interest is the human peptide GHK (glycyl-L-histidyl-L-lysine), a copper-binding peptide known for its diverse biological actions that have been studied in the context of aging-related diseases and conditions. GHK has shown effects on various tissues, including chondrocytes, liver cells, and human fibroblasts, as documented in research. Importantly, studies using the Broad Institute Connectivity Map have demonstrated that GHK can modulate gene expression, with observed effects on resetting pathological patterns toward healthier states.

In research focused on the nervous system, GHK has demonstrated neuroprotective effects in models of neurodegenerative diseases and improved tissue regeneration. A study on rats with intracerebral hemorrhage (ICH) revealed that GHK pretreatment significantly improved neurological deficits, reduced brain water content, and inhibited neuronal apoptosis. The peptide's effects were mediated through the downregulation of miR-339-5p expression, which was found to be part of the p38 MAPK pathway. Additionally, GHK's influence on the miR-339-5p/VEGFA axis played a crucial role in preventing neuronal apoptosis following ICH injury. These findings suggest that GHK could represent a novel area of research investigation for conditions like ICH.

GHK-Cu, a variant of the peptide found in high concentrations in the brain, has been studied for its ability to counteract age-associated decline in neuron function. Research indicates that GHK-Cu influences angiogenesis in the nervous system, nerve outgrowth, and central nervous system inflammation. It appears to reset pathological gene expression, with observed effects on restoring function in dysfunctional systems. In rat models, GHK-Cu's neuroprotective effects were evident through improved neurological deficits, reduced brain swelling, and inhibition of neuron death. These effects were particularly notable in the context of overexpression of miR-339-5p following brain injuries such as bleeds and strokes, underscoring GHK-Cu's potential as a research subject in the context of neurodegeneration.

[8], [9]

GHK peptide shows promise in inhibiting bleomycin-induced pulmonary fibrosis in mice by suppressing the TGF-β1/Smad-mediated epithelial-to-mesenchymal transition (EMT). Pulmonary fibrosis, an irreversible and progressive lung disease, lacks effective treatments. It occurs after therapy with bleomycin – cancer drug. GHK, a tripeptide known for its role in tissue regeneration and wound healing, was tested for its effects on bleomycin-induced fibrosis. Mice were administered GHK intraperitoneally at various doses following bleomycin instillation. Results demonstrated that GHK treatment reduced inflammatory cell infiltration, improved collagen deposition, and balanced MMP-9/TIMP-1 levels. It also decreased TNF-α, IL-6 in bronchoalveolar lavage fluid, and myeloperoxidase activity in lung extracts. GHK further inhibited TGF-β1, p-Smad2, p-Smad3, and IGF-1 expression, indicating its potential as a subject of further research in pulmonary fibrosis by targeting the TGF-β1/Smad 2/3 and IGF-1 pathways.

GHK-Cu, the copper-bound form of the peptide, also exhibits protective effects against lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. GHK-Cu treatment reduced reactive oxygen species (ROS) production, increased superoxide dismutase (SOD) activity, and decreased TNF-α and IL-6 production by inhibiting NF-κB p65 and p38 MAPK signaling in LPS-induced macrophages and ALI models. This treatment alleviated lung histological alterations and suppressed inflammatory cell infiltration, demonstrating GHK-Cu's potential as a novel research subject for ALI and acute respiratory distress syndrome (ARDS) by mitigating excessive inflammatory responses.

Research highlights the observed activity of GHK-Cu in protecting lungs from fibrosis following bleomycin therapy, suggesting its potential interest as a chemotherapy adjuvant research subject to investigate increased medication doses without exacerbating side effects. GHK-Cu regulates inflammatory molecules TNF-α and IL-6, with observed effects on fibrotic remodeling and collagen deposition in the lungs. Similarly, GHK-Cu showed notable findings in mouse models of ARDS, reducing TNF-α and IL-6 expression, and demonstrating a protective effect against this rapid and potentially fatal inflammatory lung condition. These findings support further research into GHK-Cu in the context of various lung injuries and diseases.

[10], [11]

GHK-Cu exhibits promising analgesic and anti-aggressive effects in rat models, particularly in response to pain-induced aggressive-defensive behavior. Administered intraperitoneally in doses ranging from 5 to 150 μg/kg, GHK-Cu demonstrated significant pain relief and reduction in aggressive behavior in a foot-shock model. The key to these effects lies in the L-lysine residue within the GHK peptide, as similar analgesic and anti-aggressive effects were observed with L-lysine administration at equivalent doses.

Furthermore, the peptide's activity extends to interactions with L-arginine, another amino acid with analgesic properties. Research has shown that combining arginine with glyprolines to form specific peptides can produce intrinsic regulatory effects on pain and aggression. This suggests that GHK-Cu and related peptides could be investigated as potential non-addictive research alternatives in the context of pain management, alongside opiate medications and NSAIDs, which are known for their potential side effects, including negative impacts on cardiovascular health. These findings highlight the research interest of GHK-Cu in pain-related studies, opening a potential avenue for developing safer pain relief approaches.

[12], [13]

All presented information is based on scientific publications which can be found in

For laboratory purposes and personal observation only. Not for human consumption.

Laboratory care

Handling

Peptides in transport

Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

Storage of lyophilized peptides

Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Up to 3 months
  • Refrigerated (2–8 °C): Up to 6 months
  • Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)

Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.

Storage of reconstituted peptides

Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.

The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Avoid prolonged storage
  • Refrigerated (2–8 °C): Typically 4–8 weeks
  • Frozen (-20 °C or below): Up to 3–4 months

To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.

Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.

Analytical documentation

Tests

Latest published result

Liquilabs s.r.o.Signed Certificate of Analysis · 50mg

> 99.8%Purity by HPLC

Batch number
4330988
Tested
2026-07-27

Recorded QC panel

AssayPeptide screening
44.4 mg
PurityPeptide screening
> 99.8%
Identity (FTIR)FTIR spectrum
987
Identity (RT)Retention time
1.000
Bacterial EndotoxinUSP / Eur. Ph. 2.6.14
0.004 EU/mg
Molecular Ion MassMS deconvolution
341 Da

These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.

See all test results

Signed certificate

Source record

References

1.

L. Pickart, J. M. Vasquez-Soltero, and A. Margolina, "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration," BioMed Res. Int., vol. 2015, p. 648108, 2015. [BioMed Research International]

2.

A. Gruchlik, E. Chodurek, and Z. Dzierzewicz, "Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts," Acta Pol. Pharm., vol. 71, no. 6, pp. 954–958, Dec. 2014. [PubMed]

3.

L. Pickart and A. Margolina, "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data," Int. J. Mol. Sci., vol. 19, no. 7, Jul. 2018. [PubMed]

4.

X. Wang et al., "GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis," Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc., vol. 25, no. 2, pp. 270–278, 2017. [PubMed]

5.

M. Kukowska, M. Kukowska-Kaszuba, and K. Dzierzbicka, "In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections," Bioorg. Med. Chem. Lett., vol. 25, no. 3, pp. 542–546, Feb. 2015. [Science Direct]

6.

G. D. Mulder et al., "Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper," Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc., vol. 2, no. 4, pp. 259–269, Oct. 1994. [PubMed]

7.

S. O. Canapp et al., "The effect of topical tripeptide-copper complex on healing of ischemic open wounds," Vet. Surg. VS, vol. 32, no. 6, pp. 515–523, Dec. 2003. [PubMed]

8.

L. Pickart, J. M. Vasquez-Soltero, and A. Margolina, "The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline," Brain Sci., vol. 7, no. 2, Feb. 2017. [PubMed]

9.

H. Zhang, Y. Wang, and Z. He, "Glycine-Histidine-Lysine (GHK) Alleviates Neuronal Apoptosis Due to Intracerebral Hemorrhage via the miR-339-5p/VEGFA Pathway," Front. Neurosci., vol. 12, p. 644, 2018. [PubMed]

10.

X.-M. Zhou et al., "GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition," Front. Pharmacol., vol. 8, p. 904, 2017. [PubMed]

11.

J.-R. Park, H. Lee, S.-I. Kim, and S.-R. Yang, "The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice," Oncotarget, vol. 7, no. 36, pp. 58405–58417, Sep. 2016. [PubMed]

12.

L. А. Sever'yanova and M. E. Dolgintsev, "Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats," Bull. Exp. Biol. Med., vol. 164, no. 2, pp. 140–143, Dec. 2017. [Springer]

13.

L. А. Sever'yanova and D. V. Plotnikov, "Binding of Glyprolines to L-Arginine Inverts Its Analgesic and Antiagressogenic Effects," Bull. Exp. Biol. Med., vol. 165, no. 5, pp. 621–624, Sep. 2018. [PubMed]

14.

Badenhorst T, Svirskis D, Merrilees MJ, et al. · 2016

Physicochemical characterization of native glycyl-l-histidyl-l-lysine tripeptide for wound healing and anti-aging: a preformulation study for dermal delivery

Physicochemical and stability characterisation of GHK-Cu.

Pharmaceutical Development and Technology · 10.3109/10837450.2014.979944 View source ↗
15.

National Center for Biotechnology Information

PubChem Compound Summary: GHK-Cu

Authoritative identity record for the GHK-Cu copper-peptide complex.

PubChem View source ↗
16.

Chemical Abstracts Service

CAS Common Chemistry: 49557-75-7

Authoritative CAS Registry Number record for GHK-Cu.

CAS Common Chemistry View source ↗
17.

National Center for Biotechnology Information

PubChem compound record

PubChem View source ↗
18.

Pickart L, Margolina A · 2018

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

International journal of molecular sciences View source ↗
19.

Pickart L, Vasquez-Soltero JM, Margolina A · 2015

GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration

BioMed research international View source ↗
20.

A. Gruchlik, E. Chodurek, and Z. Dzierzewicz · 2014

Effect of GLY-HIS-LYS and its copper complex on TGF-β secretion in normal human dermal fibroblasts

Acta Pol. Pharm
21.

X. Wang et al. · 2017

GHK-Cu-liposomes accelerate scald wound healing in mice by promoting cell proliferation and angiogenesis

Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc
22.

M. Kukowska, M. Kukowska-Kaszuba, and K. Dzierzbicka · 2015

In vitro studies of antimicrobial activity of Gly-His-Lys conjugates as potential and promising candidates for therapeutics in skin and tissue infections

Bioorg. Med. Chem. Lett
23.

G. D. Mulder et al. · 1994

Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper

Wound Repair Regen. Off. Publ. Wound Heal. Soc. Eur. Tissue Repair Soc
24.

S. O. Canapp et al. · 2003

The effect of topical tripeptide-copper complex on healing of ischemic open wounds

Vet. Surg. VS
25.

L. Pickart, J. M. Vasquez-Soltero, and A. Margolina · 2017

The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline

Brain Sci
26.

H. Zhang, Y. Wang, and Z. He · 2018

Glycine-Histidine-Lysine (GHK) Alleviates Neuronal Apoptosis Due to Intracerebral Hemorrhage via the miR-339-5p/VEGFA Pathway

Front. Neurosci
27.

X.-M. Zhou et al. · 2017

GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition

Front. Pharmacol
28.

J.-R. Park, H. Lee, S.-I. Kim, and S.-R. Yang · 2016

The tri-peptide GHK-Cu complex ameliorates lipopolysaccharide-induced acute lung injury in mice

Oncotarget
29.

L. А. Sever'yanova and M. E. Dolgintsev · 2017

Effects of Tripeptide Gly-His-Lys in Pain-Induced Aggressive-Defensive Behavior in Rats

Bull. Exp. Biol. Med
30.

L. А. Sever'yanova and D. V. Plotnikov · 2018

Binding of Glyprolines to L-Arginine Inverts Its Analgesic and Antiagressogenic Effects

Bull. Exp. Biol. Med

Customer reviews

4.7/5185+ reviews
View on Trustpilot ↗Checked 17 Nov 2026

Quality products,fast shipping,great refferal plan,only downside is that products in 4 mounths since my first order got more and more expensive ,but overall verry good experience.

Read full review →

More than 2 weeks for package dispatch. They promised one free peptide next time. Sent me new tracking number but package still wasn't delivered to fedex. Last package (much much cheaper) was delivered in less than week. I will update if they will send my package. ok,package sent.

Read full review →

Extremely satisfied with the product quality and overall experience. The customer service is polite and quick. All recommendations!

Read full review →

Trustworthy site with a huge catalog of products. Been purchasing from them for some time now never got disappointed. I could only recommend them.

Read full review →

Everything ok. With little problem with package, but after contact with Customer Service everything went right. Good quality of products

Read full review →

Excellent. Buying peptides online can be nerve wracking! But Adria are very transparent about all the checks and certifications. My experience with them was excellent. Great products at good prices and efficient P&P

Read full review →